Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics Statistics

Total Valuation

CVKD has a market cap or net worth of $22.20 million. The enterprise value is $16.02 million.

Market Cap	22.20M
Enterprise Value	16.02M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CVKD has 1.97 million shares outstanding. The number of shares has increased by 43.28% in one year.

Current Share Class	1.97M
Shares Outstanding	1.97M
Shares Change (YoY)	+43.28%
Shares Change (QoQ)	+12.46%
Owned by Insiders (%)	29.34%
Owned by Institutions (%)	7.73%
Float	1.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.71
P/TBV Ratio	3.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.32

Current Ratio	4.32
Quick Ratio	4.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -208.59% and return on invested capital (ROIC) is -133.24%.

Return on Equity (ROE)	-208.59%
Return on Assets (ROA)	-109.43%
Return on Invested Capital (ROIC)	-133.24%
Return on Capital Employed (ROCE)	-214.83%
Revenue Per Employee	n/a
Profits Per Employee	-$3.21M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.92% in the last 52 weeks. The beta is 0.98, so CVKD's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	+79.92%
50-Day Moving Average	13.53
200-Day Moving Average	15.62
Relative Strength Index (RSI)	43.15
Average Volume (20 Days)	36,352

Short Selling Information

The latest short interest is 19,939, so 1.01% of the outstanding shares have been sold short.

Short Interest	19,939
Short Previous Month	19,643
Short % of Shares Out	1.01%
Short % of Float	1.43%
Short Ratio (days to cover)	0.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.13M
Pretax Income	-6.24M
Net Income	-12.83M
EBITDA	-13.13M
EBIT	-13.13M
Earnings Per Share (EPS)	-$9.08

Balance Sheet

The company has $7.34 million in cash and n/a in debt, giving a net cash position of $7.34 million or $3.73 per share.

Cash & Cash Equivalents	7.34M
Total Debt	n/a
Net Cash	7.34M
Net Cash Per Share	$3.73
Equity (Book Value)	6.11M
Book Value Per Share	3.20
Working Capital	6.10M

Cash Flow

In the last 12 months, operating cash flow was -$10.17 million and capital expenditures -$9,788, giving a free cash flow of -$10.18 million.

Operating Cash Flow	-10.17M
Capital Expenditures	-9,788
Free Cash Flow	-10.18M
FCF Per Share	-$5.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CVKD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.28%
Shareholder Yield	-43.28%
Earnings Yield	-54.95%
FCF Yield	-43.59%

Analyst Forecast

The average price target for CVKD is $32.00, which is 183.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	183.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-22.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 20, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 20, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1